XML 15 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
OPERATING ACTIVITIES    
Net loss $ (310) $ (1,903)
Non cash items:    
Depreciation and amortization 134 117
Non-cash stock-based compensation 32 158
Reduction in JV losses recognized (946)  
Change in other operating items:    
Other current assets 152 195
Accounts payable 71 8
Other accrued liabilities 37 (102)
Cash flows used in operating activities (830) (1,527)
INVESTING ACTIVITIES    
Cash flows provided by investing activities 0 0
FINANCING ACTIVITIES    
LipimetiX Development, Inc. Series B-1 Preferred Stock sale, net of issuance costs 946 0
Cash flows provided by financing activities 946 0
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 116 (1,527)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 1,011 2,164
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 1,127 $ 637